WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity Technologies, Inc. (NASDAQ: BIAF) (NASDAQ: BIAFW), a cancer diagnostics company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, and is researching targeted therapies to treat cancer, priced its initial public offering of 1,282,600 units of securities at $6.125 per unit.